[1] Di Pietro M, S Filardo, S Cazzavillan, et al. Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain? [J].J Biol Regul Homeost Agents, 2013, 27(1):155-164.[2] Christine J Hammond, Loretta R Hallock, R J Howanski, et al. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain [J].BMC Neurosci, 2010, 11(1):121.[3] 杨新玲, 刘雪晴, 杨杰民. 肺炎衣原体感染与阿尔茨海默病的关系[J]. 中国人兽共患病学报, 2013, 29(2):195-198.[4] Maryam Aghaei, Fereshteh Ashtari, Mohammadali Bahar, et al. Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study [J].Neurol Neurochir Pol, 2011, 45(2):128-131.[5] Luo Jian-hua, Jia Tian-jun, Zhong You-min, et al.Localization of the hypothetical protein Cpn0585 in the inclusion membrane of Chlamydia pneumoniae-infected cells[J]. Microb Pathog, 2007, 42(2-3):111-116.[6] Luo Jian-hua, Jia Tian-jun, R Flores, et al.Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniaeinclusion membrane[J]. Infect Immun, 2007, 75(1):497-503.[7] Luo Jian-hua, Liu Guang-chao, Zhong You-min,et al.Characterization of hypothetical proteins Cpn0146, 0147, 0284 & 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane[J]. BMC Microbiol, 2007, 7(1):38.[8] Takeda S. High quality and high throughput yeast two-hybrid system[J]. Tanpakushitsu Kakusan Koso, 2004, 49(17 Suppl): 2751-2757.[9] Jung-Min Yoon, Masatoshi Nakajima, Kiyoshi Mashiguchi, et al. Chemical screening of an inhibitor for gibberellin receptors based on a yeast two-hybrid system[J].Bioorg Med Chem Lett, 2013, 23(4):1096-1098 |